Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director
Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director
-
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern...
-
BALA CYNWYD, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...
-
Selskabsmeddelelsefor ROCKWOOL A/SMeddelelse nr. 12 - 2026til Nasdaq Copenhagen 15. april 2026 Forløb af den ordinære generalforsamling 2026 ROCKWOOL A/S har den 15. april 2026, kl. 15.00, afholdt...
-
Company announcementfor ROCKWOOL A/SRelease no. 12 - 2026to Nasdaq Copenhagen 15 April 2026 Minutes of Annual General Meeting 2026 The annual general meeting of ROCKWOOL A/S was held on 15...
-
New York, USA, April 15, 2026 (GLOBE NEWSWIRE) -- Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight The generalized...
-
Paris – 15 April 2026 Convening of the Annual General Meeting of Banijay Group N.V. Banijay Group N.V. today announced that the Annual General Meeting (“General Meeting”) will take place on...
-
Allschwil, 15. April 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
-
Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
-
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....